Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Quaternium-15 is a synthetic quaternary ammonium salt used primarily as a surfactant and preservative in cosmetics, personal care products, and various industrial applications. It acts as an antimicrobial agent by slowly releasing formaldehyde, which provides biocidal properties. This mechanism also makes it a known human skin toxicant and allergen, capable of causing contact dermatitis especially in sensitive individuals. Quaternium-15 is approved for use in allergenic epicutaneous patch tests to aid the diagnosis of allergic contact dermatitis in persons aged six years or older. The compound exists as a mixture of cis and trans isomers; the cis form (Dowicil 200) is mainly used in cosmetics at concentrations up to 0.2% (EU limit), while mixed forms are found in industrial products such as paints, adhesives, metalworking fluids, and cleaning agents[3][5][6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on quaternium-15.